2023 - Research.com Best Female Scientist Award
2023 - Research.com Microbiology in France Leader Award
2022 - Research.com Best Female Scientist Award
Her primary scientific interests are in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Sida. Her Internal medicine research includes themes of Gastroenterology and Surgery. Her Immunology research integrates issues from Cytotoxic T cell, Cause of death and Virology.
Her Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Epidemiology, Cohort study, Viral disease, Hepatitis and Confidence interval. Her studies in Cohort study integrate themes in fields like Mortality rate and Antiretroviral therapy. Her Viral load study incorporates themes from Protease inhibitor, Pharmacotherapy, Immunogenicity and Risk factor.
Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Virology are her primary areas of study. Her Internal medicine research includes themes of Gastroenterology and Surgery. Her Antibody, CD8 and Immune system study in the realm of Immunology interacts with subjects such as Cart.
Her work investigates the relationship between Acquired immunodeficiency syndrome and topics such as Viral disease that intersect with problems in Immunopathology. Dominique Costagliola has included themes like Young adult, Regimen, Efavirenz, Hazard ratio and Prospective cohort study in her Viral load study. Dominique Costagliola has researched Virology in several fields, including Protease inhibitor, Drug resistance and Genotype.
Her primary areas of investigation include Internal medicine, Cohort, Viral load, Incidence and Confidence interval. Her Internal medicine study combines topics in areas such as Gastroenterology and Oncology. Dominique Costagliola interconnects Etravirine, Regimen, Acquired immunodeficiency syndrome and Pediatrics in the investigation of issues within Viral load.
Her Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Disease and Poisson regression. Her studies deal with areas such as Cancer, Men who have sex with men and Kidney disease as well as Incidence. As a member of one scientific family, she mostly works in the field of Confidence interval, focusing on Young adult and, on occasion, Epidemiology and CD8.
Dominique Costagliola mostly deals with Internal medicine, Cohort, Viral load, Pediatrics and Observational study. Her Internal medicine study frequently draws connections to other fields, such as Gastroenterology. Her work deals with themes such as Odds ratio, Schizophrenia, Psychiatry and Metabolic syndrome, which intersect with Cohort.
Her Viral load research includes elements of Confidence interval, Hazard ratio, Acquired immunodeficiency syndrome and Confounding. Her research in the fields of Hiv testing overlaps with other disciplines such as Disease prevention. Her work carried out in the field of Pediatrics brings together such families of science as Relative risk, Randomized controlled trial and Antiretroviral treatment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel.
PLOS Pathogens (2013)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida;David A. Price;David A. Price;Laura Papagno;Zaïna Aït Arkoub.
Journal of Experimental Medicine (2007)
Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies
J Gill;Margaret T May;C Lewden;M Saag.
Clinical Infectious Diseases (2010)
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.
Murielle Mary-Krause;Laurent Cotte;Anne Simon;Maria Partisani.
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
Marguerite Guiguet;François Boué;Jacques Cadranel;Jean-Marie Lang.
Lancet Oncology (2009)
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.
Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport.
Annals of Internal Medicine (2000)
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua.
International Journal of Epidemiology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: